GEODE CAPITAL MANAGEMENT, LLC

Position in TECX — Tectonic Therapeutic, Inc.

CIK 1214717 BOSTON, MA

Position in TECX

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$9,298,449

+$1,006,132 QoQ

Shares Held

270,461

+0.8% QoQ

Ownership

1.38%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#13

of 122 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $21,877,764,044 across 520 Biotechnology names. TECX ranks #195 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,017,848	$2,989,245,636
2	REGN	Regeneron Pharmaceuticals, Inc.	2,625,810	$1,637,297,566
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,635,840	$793,466,914
4	RVMD	Revolution Medicines, Inc.	3,942,676	$738,384,360
5	MRNA	Moderna, Inc.	9,710,335	$680,014,759
6	INCY	Incyte Corp	4,750,735	$538,543,319
7	RPRX	Royalty Pharma plc	8,058,048	$451,814,751
8	INSM	INSMED Inc	4,220,155	$449,952,925

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$9,298,449	270,461	+0.8%	Shares	Defined	2026-08-12
2026-03-31	$8,292,317	268,273	+1.8%	Shares	Defined	2026-05-15
2025-12-31	$5,497,861	263,560	-2.2%	Shares	Defined	2026-02-09
2025-09-30	$4,226,147	269,353	-1.1%	Shares	Defined	2025-11-12
2025-06-30	$5,409,745	272,257	+242.5%	Shares	Defined	2025-08-08
2025-03-31	$1,407,714	79,487	+2.5%	Shares	Defined	2025-05-13
2024-12-31	$3,582,052	77,584	+0.9%	Shares	Defined	2025-02-12
2024-09-30	$2,329,432	76,879	+147.7%	Shares	Defined	2024-11-12
2024-06-30	$511,112	31,033	—	Shares	Defined	2024-08-09
No filing history on record for this holder in this stock.